Marshall Financial Group LLC Zoetis Inc. Transaction History

Marshall Financial Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	BUY	$148.29 - $182.55 $40,186 - $49,471	271 Added 3.04%	9,196 $1.36 Million
Q2 2022 Jul 25, 2022	BUY	$155.97 - $200.09 $289,792 - $371,767	1,858 Added 26.29%	8,925 $1.53 Million
Q1 2022 May 10, 2022	BUY	$181.39 - $234.03 $72,737 - $93,846	401 Added 6.02%	7,067 $1.33 Million
Q4 2021 Jan 27, 2022	SELL	$193.69 - $247.03 $6,779 - $8,646	-35 Reduced 0.52%	6,666 $1.63 Million
Q3 2021 Oct 28, 2021	BUY	$189.29 - $209.69 $70,983 - $78,633	375 Added 5.93%	6,701 $1.3 Million
Q2 2021 Jul 14, 2021	SELL	$155.9 - $187.99 $102,738 - $123,885	-659 Reduced 9.43%	6,326 $1.18 Million
Q1 2021 Apr 20, 2021	BUY	$144.0 - $169.39 $50,112 - $58,947	348 Added 5.24%	6,985 $1.1 Million
Q4 2020 Jan 29, 2021	BUY	$157.07 - $174.35 $1.04 Million - $1.16 Million	6,637 New	6,637 $1.1 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Marshall Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Marshall Financial Group LLC with notifications on news.